CLEMASTINUM WZF Polfa 1 mg tablets
chlorpheniramine, clemastine
Note. This product is not distributed or sold, and information is provided for information purposes only.
For more detailed information, contact your nearest pharmacy, pharmacist or your family doctor.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet You may need to read it.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine is only for you, so the others can not give. It may harm them (even if their symptoms are the same as yours).
- If you get side effects (even if it is not listed), ask your doctor or pharmacist. See. Chapter 4.
What is in this leaflet?
- What is CLEMASTINUM WZF Polfa is and what it is used for
- Before you CLEMASTINUM WZF Polfa
- How CLEMASTINUM WZF Polfa
- Possible side effects
- How to store CLEMASTINUM WZF Polfa
- Contents of the pack and other information
- What is CLEMASTINUM WZF Polfa is and what it is used for
CLEMASTINUM WZF Polfa is a drug allergy. It reduces allergy symptoms, especially if there is a skin disorder or a runny nose.
CLEMASTINUM WZF Polfa treat the following disorders.
- Before you CLEMASTINUM WZF Polfa
CLEMASTINUM WZF Polfa Do not
- If you are allergic to chlorpheniramine, clemastine or any of the other ingredients of this medicine (listed in section 6);
- If you are allergic to any other similar structure of the material, eg., Chlorpheniramine, diphenhydramine;
- If you suffer from porphyria (a rare metabolic disorder);
- If the patient is younger than 12 months;
- If concomitant use of monoamine oxidase (MAO) inhibiting drugs.
Warnings and Precautions
Check with your doctor before you start taking CLEMASTINUM WZF Polfa
- If you have narrow-angle glaucoma or increased pressure in the eyes;
- If you have peptic ulcer disease or abnormal loss of food in the stomach and duodenum;
- If you have the stomach pyloric obstruction;
- If you are symptomatic prostatic hyperplasia or for any other reason, the former urinary retention;
- if is asthma;
- If you are too strong thyroid gland;
- in case of cardiovascular disorders and high blood pressure disease:
- If the patient is elderly (over 60 years), as this may result in stronger side effects (eg., Drowsiness, fatigue, arterial blood pressure).
If this condition was before, it is necessary to tell your doctor.
Other medicines and CLEMASTINUM WZF Polfa
If you are taking or have recently taken any other medicines, or because you are not sure, talk to your doctor or pharmacist.
If chlorpheniramine, clemastine administered with central nervous system depressants, eg., Barbiturates (causing a sedative and sedative effects), tricyclic antidepressants (for depression), therapy for parkinsonism, opioid pain medications may enhance the central nervous system depression, and such combinations should be used with caution.
Certain medicines to treat depression (monoamine oxidase (MAO) inhibitors) may prolong and enhance the impact of chlorpheniramine, clemastine.
Chlorpheniramine, clemastine strengthens alcoholic effect on the central nervous system.
CLEMASTINUM WZF Polfa with food and drink
CLEMASTINUM WZF Polfa can be administered without regard to food.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, you think you may be pregnant or planning to become pregnant before taking this medicine, talk to your doctor or pharmacist.
gestation period
During pregnancy this product should only be used in emergencies.
Lactation
Slightly chlorpheniramine, clemastine passes into breast milk and may cause side effects in nursing infants.
Driving and using machines
Chlorpheniramine, clemastine may cause some side effects (drowsiness, fatigue, dizziness), so to drive or operate machinery.
CLEMASTINUM WZF Polfa contains lactose
If your doctor has told you that you have intolerance to some sugars, contact your doctor before you start taking this medicine.
- How CLEMASTINUM WZF Polfa
Always take this medicine exactly as directed by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
Adults and children over 12 years of age
It should take 1 tablet (1 mg) twice daily, morning and evening. If necessary, the dose may be increased to 3 - to 4 tablets.
1 - 12 of years of age
CLEMASTINUM WZF Polfa 1 mg in these patients should not be used. It is recommended to use chlorpheniramine, clemastine other formulations, such as., Syrup (that dosage would be more accurate).
If it is considered that CLEMASTINUM WZF Polfa is too strong or too weak, talk to your doctor or pharmacist.
If you take too much CLEMASTINUM WZF Polfa dose?
Children may experience agitation, hallucinations, movement coordination extinction, muscular incoordination, muscle tremors, involuntary movements, fever (hyperthermia), skin pamėlimas, seizures, body (nervous system) response to environmental stimuli worsened, turning into a depression, and heart breaks.
You may experience dry mouth, dilated pupils, flushing, fever. Adults tend to be a central nervous system depression, which manifests itself in drowsiness and even coma.
If, after oral administration for less than an hour, it can be useful for gastric lavage. If overdose earlier than an hour ago, symptomatic treatment.
If you take more than you intended, you should immediately contact your doctor or pharmacist.
If you forget to CLEMASTINUM WZF Polfa
Do not take a double dose to make up for a missed dose.
- Possible side effects
This medicine, like all others, can cause side effects, although not everybody gets them.
Below are listed by frequency divided possible side effects.
Common (affects less than 1 in 10 patients):
- Fatigue (especially in children and adolescents over 60 years of age);
- Increased sleepiness (especially children and older than 60 years of age).
Uncommon (less than 1 in 100 patients):
- Dizziness.
Rare (less than 1 in 1 000) of:
- Headache, irritability (especially in children);
- Dry mouth, nausea;
- Rash;
- Weakness.
Very rare (less than 1 in 10, 000):
- constipation;
- Palpitations, rapid heartbeat.
Not known (can not be estimated from the available data):
- Heartburn, vomiting, abdominal pain, diarrhea;
- Tremors, insomnia, seizures;
- Visible blur visible ghosting;
- Ringing in the ears;
- Respiratory secretion density increase in nasal congestion sensation;
- Low blood pressure (especially older than 60 years of age);
- Premature contractions of the heart;
- Blood cells (thrombocytopenia, granuliozitų reduction, hemolytic anemia);
- Urinary difficulty, urinary retention.
If you experience side effects, including not listed, please tell your doctor, pharmacist or nurse. The side effects can also report directly by filling out the web site www.vvkt.lt the form by mail to the State Medicines Control Agency under the Lithuanian Ministry of Health, Žirmūnų g. 139A, LT 09120 Vilnius Tel: 8 800 73 568, fax 8 800 20131 or e-mail. Email NepageidaujamaR@vvkt.lt.
When reporting side effects you can help us to get more information about the safety of the medicine.
- How to store CLEMASTINUM WZF Polfa
Keep this medicine out of the sight and reach of children place.
Do not store above 25 ° C.
Keep the blister in the outer carton in order to protect from moisture and light.
On the carton and blister after EXP after the expiry date of this medicine. The expiry refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. How to dispose of unwanted medication, ask your pharmacist. These measures will help to protect the environment.
- Contents of the pack and other information
CLEMASTINUM WZF Polfa composition
- The active substance is chlorpheniramine, clemastine. Each tablet contains 1.34 mg of chlorpheniramine, clemastine fumarate, equivalent to 1 mg chlorpheniramine, clemastine.
- The other ingredients are lactose monohydrate, rice starch, povidone, magnesium stearate, talc.
CLEMASTINUM WZF Polfa appearance and contents of the pack
The tablets are white, round, smooth surface on both sides, with a sharp Brauna.
CLEMASTINUM WZF Polfa available in blister. Carton contains 30 tablets.
Marketing Authorisation Holder and Manufacturer
Warszawskie Zakłady Pharmaceutical Polfa SA
- Karolkowa 22/24, 01-207 Warszawa, Poland
For any information about this medicine, please contact the Marketing Authorisation Holder:
Warszawskie Zakłady Pharmaceutical Polfa SA
- Karolkowa 22/24, 01-207 Warszawa, Poland
This leaflet was last revised in 2014-07-22